#
BFB home
#

April 15, 1988


VIII.  PROCEDURES FOR ISSUING ORDERS

       A.  The Department Chair or Principal Investigator must determine the 
           need for and sign all requisitions for Controlled Substances.

       B.  Controlled Substances listed under Schedules I and II can only be 
           ordered on Form DEA 222.  The form shall be prepared as follows:

           1.  The form shall be prepared by use of a typewriter, pen, or 
               indelible pencil.

           2.  There are 10 lines on each form.  Only one item may be 
               entered on each numbered line.  If one order form is 
               insufficient to include all items in an order, additional 
               forms must be used.  Do not attach a separate list of items.

           3.  The total number of items ordered shall be noted on the form 
               in the space provided.

           4.  The name and address of the supplier from whom the items are 
               being ordered must be entered on the form.  Only one supplier 
               may be listed on any one form.

           5.  Only the Authorized Individual or the alternate, the 
               attorney-in-fact, may sign the form.

           6.  Copy 1 and Copy 2 of the order form shall be sent to the 
               supplier.  Copy 3 shall be retained for the files.

           7.  The order forms shall not be used for substances other than 
               Controlled Substances listed in Schedules I and II.

       C.  Controlled Substances listed under Schedules III, IV, and V can be 
           secured by issuance of a standard University purchase order.  
           Only the Authorized Individual or the alternate, the 
           Attorney-in-Fact, shall sign the purchase order.  If the purchase 
           order is issued as a blanket order with a specific vendor, 
           records must be maintained for each Controlled Substance 
           delivered under the blanket order.  Such records shall be in 
           accordance with the provisions of Section X of this Bulletin.

IX.  SECURITY

     Effective controls and procedures shall be established to guard against 
     theft and diversion of Controlled Substances.

     A.  A receiving report shall be made out which will provide for the 
         signature of each individual through whose hands a Controlled 
         Substance passes up to and including the ultimate user.  (See 
         Section X.B.  of this Bulletin).

     B.  Physical security controls shall be commensurate with the schedules 
         and quantity of Controlled Substances in the possession of the 
         ultimate user and such controls shall be in effect at any 
         intermediate in-travel point where the item may be held.  
         Generally, a securely locked, substantially constructed cabinet or 
         a locked safe will provide adequate security for storage.

     C.  Access to Controlled Substances shall be restricted to the absolute 
         minimum number of individuals needed and authorized to handle daily 
         transactions in such items.

     D.  Access to Controlled Substances shall be denied to any individual who 
         has had a personal application for registration with DEA denied or 
         revoked at any time.

     E.  Notification of any loss or theft of Controlled Substances shall be 
         made by the Materiel Manager immediately to the DEA Regional Office 
         and to the University of California Police Department.  A report on 
         DEA Form 106 shall be submitted to the DEA.

X.  RECORDS

    A.  The Authorized Individual or the alternate, the attorney-in-fact, 
        shall record on Copy 3 of the order form, or a copy of the standard 
        purchase order, as applicable, the date on which each item is 
        received.  A cross reference to the purchase requisition shall be 
        made.

    B.  A record shall be maintained at each in-travel point through which 
        the item passes from receipt at the campus or Laboratory until 
        delivery to the ultimate user.  This record shall include the item, 
        quantity, order number, and signature of individual receiving the 
        package.

    C.  The ultimate user shall maintain records which will include the 
        following;

        1.  Name of the substance.

        2.  The finished form (such as 10 mg.  tablet, or 10 mg.  
            concentration per fluid ounce or milliliter) for each substance 
            and the number of units or volume of finished form in each 
            commercial container.

        3.  The number of commercial containers of such finished form 
            received from other persons, including the date of and number of 
            containers in each receipt, and the name, address, and 
            registration number of the person from whom the containers were 
            received.

        4.  The amount of each unit or volume or portion thereof of finished 
            form dispensed or used, including the name and address of the 
            persons to whom it was dispensed, the date of dispensing, and 
            the written or typewritten name or initials of the individual 
            who dispensed or administered the substance and the reason it 
            was dispensed or used.

        5.  The number of units or volume of the finished forms and/or 
            commercial containers disposed of in any other manner, including 
            the date and manner of disposal.  (See Section XII Disposal, 
            below.)

    D.  For Schedule I and II items, the inventory records shall be 
        maintained separately from all other items.  Prescriptions for such 
        items shall be maintained in separate prescription files.

    E.  For Schedule III, IV, and V items, the inventory and records shall be 
        maintained separately or be readily available.  Prescriptions for such 
        items shall be maintained in separate prescription files.  However, 
        if prescriptions for such items are stamped in red ink in the lower 
        right-hand corner with the letter "C" no less than one inch high, 
        they may be filed with the prescriptions for Schedule I and II 
        items, or they may be filed with prescription for Noncontrolled 
        Substances.

    F.  Records shall be maintained and available to the DEA for at least two 
        years from the date of the record.

 
#

Send comments or questions about this website to Ed Baylosis.
Last updated: December 4, 2008 .